Mr Richard Burdick, CRNP in Baltimore, MD - Nurse Practitioner

Mr Richard Burdick, CRNP is a Nurse Practitioner physician based in Baltimore, Maryland. Mr Richard Burdick is licensed to practice in Maryland (license number R122529) and his current practice location is 2401 W Belvedere Ave, Lapidus Cancer Institute, Baltimore, Maryland. He can be reached at his office (for appointments etc.) via phone at (410) 601-4604.

NPI number for Mr Richard Burdick is 1548219702 and his current mailing address is 2401 W Belvedere Ave, Attn: Credentialing, Baltimore, Maryland. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1548219702.

Contact Information

	Mr Richard Burdick, CRNP
	2401 W Belvedere Ave, Lapidus Cancer Institute, Baltimore, MD 21215-5216
	(410) 601-4604
	(410) 601-4601

Physician's Profile

Full Name	Mr Richard Burdick
Gender	Male
Speciality	Nurse Practitioner
Location	2401 W Belvedere Ave, Baltimore, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1548219702
Provider Enumeration Date: 05/08/2006
Last Update Date: 11/21/2007

Medical Identifiers

Medical identifiers for Mr Richard Burdick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548219702	NPI	-	NPPES
CA8374	Other	MD	R/R MEDICARE GROUP #
257704600	Medicaid	MD
P00250047	Other	MD	R/R MEDICARE PROVIDER #

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207X00000X	Orthopaedic Surgery	R122529 (Maryland)	Secondary
363L00000X	Nurse Practitioner	R122529 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Richard Burdick is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Richard Burdick, CRNP 2401 W Belvedere Ave, Attn: Credentialing, Baltimore, MD 21215-5216 Ph: (410) 601-5524	Mr Richard Burdick, CRNP 2401 W Belvedere Ave, Lapidus Cancer Institute, Baltimore, MD 21215-5216 Ph: (410) 601-4604

News Archive

DaVita thanks nearly 1,500 renal social workers during NASW

DaVita Inc., a leading provider of kidney care services that is committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today thanks its nearly 1,500 social workers for the value and care they provide to patients and their families.

Financial exploitation of the elderly is on the rise, shows research

Researchers at Wayne State University, in collaboration with Illinois Institute of Technology, recently published a study advising clinical gerontologists in the field to be aware of older adults' needs for assessment of financial exploitation or its potential when working with highly vulnerable individuals.

GOT YOUR BACK launches The Spinalis Chair

GOT YOUR BACK will be hosting an Open House at their retail location at 521 East Hector Street, Conshohocken, PA on December 12th from 1:00 p.m. - 4:00 p.m. Guests will include health and wellness professionals, chiropractors, massage therapists and those interested in alternative fitness and wellness throughout the tri-state area. Visitors will enjoy food, beverages, a free chair massage, and free on site diagnosis of the spine. This event is also open to the public and special discounts will be offered throughout the store exclusively for attendees of this event.

Critically ill patients on antidepressants more likely to die

Researchers at Beth Israel Deaconess Medical Center, in Boston, and the Massachusetts Institute of Technology in Cambridge, have found that critically ill patients were more likely to die if they were taking the most commonly prescribed antidepressants when they were admitted to the intensive care unit (ICU).

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical today announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The "For Investigational Use Only" laboratory-based testing service uses Chronix's breakthrough approach—the Chronix Apoptotic DNA Blood Test—which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.

Mr Richard Burdick, CRNP - Nurse Practitioner in Baltimore, MD